title: [Clinical and genetic study in 22 patients with basal cell nevus syndrome].
abstract: BACKGROUND
  Nevoid basal cell carcinoma syndrome is an autosomal dominant disorder characterized by developmental abnormalities and cancer predisposition. The PTCH 1 gene, the human homolog of the Drosophila segment polarity gene patched, has been shown to be involved in the development of nevoid basal cell carcinoma syndrome. PTCH 1 is mapped to chromosome 9q22.3. The aim of the present study was to report on clinical and genetic characteristics in patients followed for nevoid basal cell carcinoma syndrome and to compare them to the data in the literature.
  
  
  METHODS
  Screening for PTCH 1 mutations was done in 22 patients followed between 1981 and 2003 for clinical suspicion of nevoid basal cell carcinoma syndrome. Clinical and radiological data were reviewed retrospectively from records. Genetic analysis was performed using blood samples after patient informed consent was obtained. When possible, DNA was also analyzed from the parents of patients in whom PTCH 1 mutations were found.
  
  
  RESULTS
  All patients had developed basal cell carcinomas: 45% palmar and plantar pitting, 62% jaw cysts and 66% calcification of falx cerebri. Medulloblastomas and meningiomas were the most common associated tumors. PTCH 1 mutations were identified in 13 patients: 6 familial cases, 3 sporadic cases and for 4 patients, it was not possible to conclude. Nine different new germ-line mutations were identified.
  
  
  CONCLUSIONS
  Genetic analysis allows molecular confirmation of diagnosis in about half of all patients. Early diagnosis is essential for detection of clinical and radiological manifestations in young patients and for provision of advice concerning protection of the skin from the sunlight.
authors.affiliation: Service de Dermatologie, Institut Gustave Roussy, Villejuif.
authors.forename: C
authors.initials: C
authors.lastname: Pruvost-Balland
authors.forename: P
authors.initials: P
authors.lastname: Gorry
authors.forename: N
authors.initials: N
authors.lastname: Boutet
authors.forename: T
authors.initials: T
authors.lastname: Magnaldo
authors.forename: G
authors.initials: G
authors.lastname: Mamelle
authors.forename: A
authors.initials: A
authors.lastname: Margulis
authors.forename: F
authors.initials: F
authors.lastname: Kolb
authors.forename: P
authors.initials: P
authors.lastname: Duvillard
authors.forename: A
authors.initials: A
authors.lastname: Spatz
authors.forename: L
authors.initials: L
authors.lastname: Brugières
authors.forename: A
authors.initials: A
authors.lastname: Chompret
authors.forename: M-F
authors.initials: MF
authors.lastname: Avril
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001478:Basal Cell Nevus Syndrome / Q000175:diagnosis / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D005260:Female; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D008875:Middle Aged; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D011956:Receptors, Cell Surface / Q000235:genetics; D012189:Retrospective Studies; D012737:Sex Factors
chemical_list: C000606236:PTCH1 protein, human; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D011956:Receptors, Cell Surface